Aprea Therapeutics Stock Forward View - Accumulation Distribution
| APRE Stock | USD 0.67 0.08 10.67% |
Aprea Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Aprea Therapeutics stock prices and determine the direction of Aprea Therapeutics's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Aprea Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the RSI of Aprea Therapeutics' share price is approaching 35. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Aprea Therapeutics, making its price go up or down. Momentum 35
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.10) | EPS Estimate Current Year (1.96) | EPS Estimate Next Year (0.74) | Wall Street Target Price 6.6667 | Quarterly Revenue Growth (0.99) |
Using Aprea Therapeutics hype-based prediction, you can estimate the value of Aprea Therapeutics from the perspective of Aprea Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Aprea Therapeutics after-hype prediction price | USD 0.74 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Aprea Therapeutics to cross-verify your projections. Aprea Therapeutics Additional Predictive Modules
Most predictive techniques to examine Aprea price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aprea using various technical indicators. When you analyze Aprea charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 574965.0 | 167684.0 |
| Check Aprea Therapeutics Volatility | Backtest Aprea Therapeutics | Information Ratio |
Aprea Therapeutics Trading Date Momentum
| On February 03 2026 Aprea Therapeutics was traded for 0.67 at the closing time. The top price for the day was 0.77 and the lowest listed price was 0.65 . The trading volume for the day was 1.1 M. The trading history from February 3, 2026 did not affect price variability. The overall trading delta against the current closing price is 5.97% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Aprea Therapeutics to competition |
Other Forecasting Options for Aprea Therapeutics
For every potential investor in Aprea, whether a beginner or expert, Aprea Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Aprea Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Aprea. Basic forecasting techniques help filter out the noise by identifying Aprea Therapeutics' price trends.Aprea Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aprea Therapeutics stock to make a market-neutral strategy. Peer analysis of Aprea Therapeutics could also be used in its relative valuation, which is a method of valuing Aprea Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Aprea Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Aprea Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aprea Therapeutics shares will generate the highest return on investment. By undertsting and applying Aprea Therapeutics stock market strength indicators, traders can identify Aprea Therapeutics entry and exit signals to maximize returns.
Aprea Therapeutics Risk Indicators
The analysis of Aprea Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Aprea Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting aprea stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.69 | |||
| Standard Deviation | 6.45 | |||
| Variance | 41.58 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Aprea Therapeutics
The number of cover stories for Aprea Therapeutics depends on current market conditions and Aprea Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aprea Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aprea Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Aprea Therapeutics Short Properties
Aprea Therapeutics' future price predictability will typically decrease when Aprea Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aprea Therapeutics often depends not only on the future outlook of the potential Aprea Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aprea Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.5 M | |
| Cash And Short Term Investments | 22.8 M |
Check out Historical Fundamental Analysis of Aprea Therapeutics to cross-verify your projections. For information on how to trade Aprea Stock refer to our How to Trade Aprea Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Will Biotechnology sector continue expanding? Could Aprea diversify its offerings? Factors like these will boost the valuation of Aprea Therapeutics. If investors know Aprea will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Aprea Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.12) | Revenue Per Share | Quarterly Revenue Growth (0.99) | Return On Assets | Return On Equity |
Understanding Aprea Therapeutics requires distinguishing between market price and book value, where the latter reflects Aprea's accounting equity. The concept of intrinsic value—what Aprea Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Aprea Therapeutics' price substantially above or below its fundamental value.
Understanding that Aprea Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aprea Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Aprea Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.